PHARMAC SOUTH is the most premier, high-powered Contract Manufacturing, Pharmaceutical & Nutraceutical Exhibition & Conference. Participants include manufacturers and trade professionals from industries as diverse as Pharma Machinery, Analytical Instruments, Lab Equipment, Herbal and Cosmetics.
PHARMAC SOUTH provides a unique forum to understand Industry trends and markets, dialogue with key technical and regulator personnel and associated stakeholders and compare notes with major suppliers of products and services in the pharmaceuticals industry.
Indian Drug Manufacturers’ Association (IDMA) was formed in 1961
Successfully completed 50 glorious years of providing affordable quality medicines, not only to our people, but people all over the world.
Membership of about 750 wholly-Indian large, medium and small companies and State Boards in Gujarat, Himachal Pradesh & Uttaranchal, Haryana, Tamil Nadu and West Bengal.
PharmaSouth is organized by a team of seasoned professionals with extensive experience in the pharmaceutical and healthcare industries. Our organizers are dedicated to creating a platform that fosters innovation, collaboration, and education, bringing together industry leaders, healthcare professionals, and innovators to drive the future of pharmaceutical advancements.
With a deep understanding of the sector’s challenges and opportunities, we are committed to delivering an event that offers exceptional value. From thought-provoking sessions to interactive exhibitions, PharmaSouth is designed to inspire meaningful connections and empower professionals to stay ahead in a rapidly evolving industry.
Turnover of Indian pharma industry has grown exponentially from Rs.10 crore (about US$ 2 million) in 1948 to about Rs. 1,00,000 crore (US $ 21 billion) today, a growth rate of over 15%.
Indian pharma industry members dominate the domestic market, holding a significant share of about 75% in formulations and approximately 85% in bulk drugs.
Members contribute significantly to India's pharmaceutical exports, accounting for about 65% of the nation's total drugs and pharma exports, reflecting their strong international presences.
Key MoUs have been signed with China Pharmaceutical Industry Association (CPIA) and the Korea Pharmaceutical Industry Association (KPMA), fostering global collaboration
With over 170 US FDA-approved facilities, 150+ EDQM-approved sites, and numerous certifications from UK-MCA, Australia, South Africa, and WHO-GMP, the industry meets the highest global standards.
India holds the 3rd position globally in production volume, contributing 10% of the world’s pharmaceutical output. However, it ranks 14th in terms of value, accounting for only 1.5% of global pharmaceutical value.
IDMA has led in supporting the Ministry of Health & Family Welfare, contributing to the Indian Pharmacopoeia and offering ongoing support to the Indian Pharmacopoeia Commission (IPC).
IDMA has been organizing the Pharmaceutical Analysts Convention (PAC) for many years, with active participation from both Central and State regulatory authorities.